QuidelOrtho Corporation (QDEL) Actualités

QuidelOrtho to Participate in Three Upcoming Investor Conferences

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies...

Form 3 - Initial statement of beneficial ownership of securities

QuidelOrtho to Report Third Quarter 2024 Financial Results

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies...

QuidelOrtho Announces New R&D Executive Leader

Jonathan Siegrist appointed as EVP of R&D and CTO QuidelOrtho Corporation (Nasdaq: QDEL), a global leader...

Form 4 - Statement of changes in beneficial ownership of securities

QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer

QuidelOrtho Corporation (Nasdaq: QDEL) is pleased to announce the appointment of Lee Bowman as Chief Human...

Form 3 - Initial statement of beneficial ownership of securities

VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.

QuidelOrtho Receives FDA 510(k) Clearance for its VITROS Syphilis Assay QuidelOrtho Corporation (Nasdaq: QDEL...

QuidelOrtho to Participate in Upcoming Investor Conferences

QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

QuidelOrtho Reports Second Quarter 2024 Financial Results

— $100 million in annualized cost-savings initiatives will benefit second half 2024 and first half 2025 — — Strong progress on business review...

Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600

Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 PR Newswire NEW YORK, July 23, 2024 NEW...

QuidelOrtho to Report Second Quarter 2024 Financial Results

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies...

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Shareholders

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation...